The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India. Pharma major Lupin has divested its entire stake in its Japanese subsidiary,......
Deal marks the largest acquisition by an Indian pharma company in the US In its fifth foreign acquisition within 18 months, Lupin on Thursday said it would acquire New Jersey-based generic......